Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple basis of combination chemotherapy.

E Mihich, G B Grindey

    Cancer
    |July 1, 1977
    PubMed
    Summary

    Combination chemotherapy explores drug interactions for enhanced cancer treatment. Strategies include cooperative effects, boosting drug effectiveness with inactive agents, and reversing toxicity for better outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Commentary on the IV São Paulo Research Conference: Cancer today: from molecular biology to treatment, São Paulo, SP, Brazil, November 10-12, 2005.

    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2006
    Same author

    Molecular targets of cancer chemotherapy.

    Cancer chemotherapy and pharmacology·2005
    Same author

    International symposium on emerging perspectives in clinical cancer research: meeting report.

    Journal of cancer research and clinical oncology·2005
    Same author

    International symposium on new leads in experimental and clinical gene targeting in cancer.

    Journal of cancer research and clinical oncology·2003
    Same author

    International symposium on molecular basis for cancer chemo- and immuno-prevention: meeting report, meeting held at Shanghai, China, Nov 29-Dec 1 2001.

    Journal of cancer research and clinical oncology·2002
    Same author

    Expression, tissue distribution, and cellular localization of the antiapoptotic TIP-B1 protein.

    Journal of leukocyte biology·2001

    Area of Science:

    • Pharmacology
    • Oncology
    • Drug Interactions

    Background:

    • Combination chemotherapy utilizes diverse drug interaction types to optimize therapeutic outcomes.
    • Understanding synergistic mechanisms at the cellular level is crucial for effective treatment design.
    • Therapeutic advantages can manifest systemically (e.g., improved bioavailability) or within tumor cells.

    Purpose of the Study:

    • To categorize and explain the different types of drug interactions in combination chemotherapy.
    • To elucidate the molecular mechanisms underlying synergistic drug effects in cancer treatment.
    • To highlight the potential benefits of combination chemotherapy for both the host and the tumor.

    Main Methods:

    • Review and categorization of existing combination chemotherapy strategies.
    • Discussion of proposed molecular mechanisms for drug synergy.
    • Analysis of therapeutic advantages at the organism and cellular levels.

    Main Results:

    • Identified three main categories of drug interactions: cooperative, enhancement by inactive agents, and toxicity reversal.
    • Detailed various proposed mechanisms for synergistic drug interactions, including enzyme inhibition and altered drug metabolism.
    • Highlighted systemic and cellular benefits of combination chemotherapy, such as reduced toxicity and enhanced drug efficacy.

    Conclusions:

    • Combination chemotherapy offers multifaceted strategies for improving cancer treatment efficacy.
    • Synergistic drug interactions can be achieved through various molecular mechanisms, leading to enhanced therapeutic effects.
    • Careful selection of drug combinations can optimize treatment outcomes by targeting both tumor cells and host responses.

    Related Experiment Videos